Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Angelini Ventures
AddedFeb 17, 2024
UpdatedJun 28, 2026
Angelini Ventures

Angelini Ventures

Operating

Angelini Ventures, a €300M venture capital fund, invests in early-stage biotech, digital health, and life sciences startups globally.

Location
Rome, Province of Rome, IT
Founded
2021
Firm
Compare
Portfolio
Employees
Website

Angelini Ventures, the venture capital arm of Angelini Industries, invests globally in early-stage biotech, digital health, and life sciences companies. With a €300 million fund, they focus on innovative solutions in brain health and consumer segments targeting women, children, and the elderly. Their investments span Europe, North America, and Israel, typically participating in Series A to C rounds.

The firm's portfolio includes notable companies such as Avation Medical, Cadence Neuroscience, and Cour Pharmaceuticals. Angelini Ventures aims to leverage technology to improve healthcare, reshape patient journeys, and address unmet needs in vulnerable populations. They offer comprehensive support to entrepreneurs throughout the company-building process and have established partnerships with top investors worldwide.

Angelini Ventures - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments6
Current Portfolio Count6
Total Portfolio Exits0

Top Investment Stages

Series A3 (50.0%)
Series C2 (33.3%)
Series B1 (16.7%)

Stage Mix

Series A 50%Series C 33%Series B 17%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Avation Medical logo

Avation Medical

Cour Pharmaceuticals Development logo

Cour Pharmaceuticals Development

Noctrix Health logo

Noctrix Health

Freya Biosciences logo

Freya Biosciences

Cadence Neuroscience logo

Cadence Neuroscience

Pretzel Therapeutics logo

Pretzel Therapeutics

Angelini Ventures - Similar Investment Firms

Angelini Lumira Biosciences Fund logo

Angelini Lumira Biosciences Fund

angelinipharma.us

Angel Funds logo

Angel Funds

Angel Invest logo

Angel Invest

ARC Angel Fund logo

ARC Angel Fund

arcangelfund.com

Archangel Ventures logo

Archangel Ventures

archangel.vc

Angular Ventures logo

Angular Ventures

Angel Investors logo

Angel Investors

invstor.com

Angel Investor logo

Angel Investor

Angle Technology Ventures logo

Angle Technology Ventures

Angel Star Ventures logo

Angel Star Ventures

Angel Capital Management logo

Angel Capital Management

acm.capital

Italian Angels for Growth logo

Italian Angels for Growth

italianangels.net

Innoangel Fund logo

Innoangel Fund

innoangel.com

Superangel logo

Superangel

superangel.io

Angel Investment Network logo

Angel Investment Network

Angelini Ventures - Classification

NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end